Suchergebnisse - "Tani, Naoki"

PubPharm (7)

1

Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection

enthalten in: Vaccine | 2023

von Goto, T. | Chong, Y. | Tani, N. | +8

2

Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants : Impact of household exposure in hospital healthcare workers

enthalten in: Vaccine | 2023

von Tani, N. | Ikematsu, H. | Goto, T. | +11

3

SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms

enthalten in: Human antibodies | 2023

von Goto, T. | Sasaki, T. | Chong, Y. | +13

4

Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents

enthalten in: Influenza and other respiratory viruses | 2022

von Chong, Y. | Goto, T. | Tani, N. | +5

5

Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine

enthalten in: Vaccine | 2022

von Tani, N. | Chong, Y. | Kurata, Y. | +9

6

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

enthalten in: PloS one | 2022

von Goto, T. | Tani, N. | Ikematsu, H. | +8

7

Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients

enthalten in: Influenza and other respiratory viruses | 2021

von Chong, Y. | Ikematsu, H. | Tani, N. | +12

CommentIn: Influenza Other Respir Viruses. 2021 May;15(3):413-414. - PMID 33131215

1
[1]